ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >protein tyrosine kinase >Tivozanib

Tivozanib

Tivozanib Structure
CAS No.
475108-18-0
Chemical Name:
Tivozanib
Synonyms
AV951;CS-8;AV-951;KRN-951;Tivozanib;TIVOZANIB;AV951;AV-951|||KRN951;AV-951(Tivozanib);Tivozanib USP/EP/BP;Tivozanib(AV951,KRN951)
CBNumber:
CB82484655
Molecular Formula:
C22H19ClN4O5
Molecular Weight:
454.86
MOL File:
475108-18-0.mol
MSDS File:
SDS
Modify Date:
2024/5/27 11:30:52

Tivozanib Properties

Melting point >202°C (dec.)
Boiling point 550.4±50.0 °C(Predicted)
Density 1.421
storage temp. Refrigerator
solubility DMSO (Slightly), Methanol (Slightly, Heated)
form White powder.
pka 11.74±0.70(Predicted)
color Pale Beige to Light Brown

Tivozanib Chemical Properties,Uses,Production

Characteristics

Primary targets: VEGFR/multikinase
Class: receptor tyrosine kinase
Treatment: RCC
Elimination half-life = 111 h
Protein binding = >99%

Uses

Tivozanib also known as AV-951 is an orally bioavailable potent VEGFR-1, 2 and 3, c-Kit and PDGFR inhibitor with IC50 of 0.21, 0.16, 0.24, 1.63 and 1.72 nM, respectively.

brand name

FotivdaTM

Mechanism of action

Tivozanib is a  tyrosine kinase inhibitor that exerts its actions by inhibiting the  phosphorylation of vascular endothelial growth factor receptor  (VEGFR)-1, VEGFR-2 and VEGFR-3 and inhibits other kinases such as c-kit  and platelet derived growth factor beta (PDGFR β).

Side effects

  • diarrhea
  • nausea
  • vomiting
  • fatigue
  • loss of appetite
  • weight loss
  • voice hoarseness
  • back pain
  • mouth sores
  • cough
  • shortness of breath

Synthesis

The synthesis of Tivozanib is as follows:
Phenyl chlorocarbonate (601 g) was added dropwise to 3-amino-5-methylisoxazole (377 g), pyridine (1215 g), and N,N-dimethylacetamide (4 L) at 0°C, and the mixture was stirred at 20°C for 2 hr. 4-[(4-Amino-3-chlorophenol)oxy]-6,7-dimethoxyquinoline (847 g) was added to the reaction solution, and the mixture was stirred at 80°C for 5 hr. The reaction solution was cooled to 5°C. Thereafter, methanol (8.5 L) and water (8.5 L) were added thereto, and the mixture was neutralized with an aqueous sodium hydroxide solution. The resultant precipitate was collected by filtration, and the filtered product was slurried in water (8.5 L) for washing. The slurry was filtered, and the filtered product was then dried under the reduced pressure to give Tivozanib (1002 g, yield 86.1%).
synthesis of Tivozanib.png

Tivozanib Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 233)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
shandong perfect biotechnology co.ltd +86-53169958659; +8618596095638 China 294 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
Shanghai Daken Advanced Materials Co.,Ltd +86-371-66670886 China 16220 58 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry

Tivozanib Spectrum

AV-951 Tivozanib N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea AV-951(Tivozanib) 1-(2-Chloro-4-(6,7-diMethoxyquinolin-4-yloxy)phenyl)-3-(5-Methylisoxazol-3-yl)urea TIVOZANIB;AV951 KRN951, TIVOZANIB) (STOPPED USE SINCE THE PATENT ISSUE N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]benzaMide Krn-951 Urea, N-(2-chloro-4-((6,7-diMethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-Methyl-3-isoxazolyl)- Tivozanib(AV951,KRN951) KRN-951 N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea Tivozanib (AV-951) TIVOZANIB (AV-951);AV-951;AV951;AV 951 N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-m... Tivozanib USP/EP/BP Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)- Tivozanib, AV951,N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea CS-8 AV-951; KRN951; AV 951;AV951 AV951 (KRN951, Tivozanib) (stopped use since the patent issue) AV951 VEGFR Tyrosine Kinase Inhibitor IV Tivozanib Lactic Acid Impurity 21 N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea AV-951|||KRN951 475108-18-0 Inhibitors Antineoplastic API